4.95
price down icon0.40%   -0.02
after-market Dopo l'orario di chiusura: 4.93 -0.02 -0.40%
loading
Precedente Chiudi:
$4.97
Aprire:
$4.96
Volume 24 ore:
1.31M
Relative Volume:
1.28
Capitalizzazione di mercato:
$259.07M
Reddito:
$44.12M
Utile/perdita netta:
$-156.25M
Rapporto P/E:
-1.6124
EPS:
-3.07
Flusso di cassa netto:
$-154.61M
1 W Prestazione:
+0.00%
1M Prestazione:
+90.38%
6M Prestazione:
+2.91%
1 anno Prestazione:
-1.20%
Intervallo 1D:
Value
$4.93
$4.96
Intervallo di 1 settimana:
Value
$4.93
$4.97
Portata 52W:
Value
$2.29
$5.90

2 Seventy Bio Inc Stock (TSVT) Company Profile

Name
Nome
2 Seventy Bio Inc
Name
Telefono
339-499-9300
Name
Indirizzo
60 BINNEY STREET, CAMBRIDGE
Name
Dipendente
65
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-25
Name
Ultimi documenti SEC
Name
TSVT's Discussions on Twitter

Confronta TSVT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
TSVT
2 Seventy Bio Inc
4.95 259.07M 44.12M -156.25M -154.61M -3.07
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 33.86B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 30.51B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 25.69B 3.81B -644.79M -669.77M -6.24

2 Seventy Bio Inc Stock (TSVT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-06-06 Downgrade Goldman Neutral → Sell
2024-01-31 Aggiornamento Leerink Partners Market Perform → Outperform
2024-01-31 Downgrade TD Cowen Outperform → Market Perform
2023-10-30 Downgrade Leerink Partners Outperform → Market Perform
2023-10-12 Iniziato Citigroup Buy
2023-09-13 Downgrade Goldman Buy → Neutral
2023-09-12 Downgrade Guggenheim Buy → Neutral
2023-07-28 Downgrade Morgan Stanley Overweight → Equal-Weight
2022-10-31 Iniziato Guggenheim Buy
2022-05-02 Iniziato Goldman Buy
2022-02-10 Iniziato SVB Leerink Outperform
2022-01-06 Iniziato Cowen Outperform
2021-11-09 Iniziato Canaccord Genuity Buy
2021-11-08 Iniziato Morgan Stanley Overweight
2021-11-08 Iniziato Wedbush Outperform
Mostra tutto

2 Seventy Bio Inc Borsa (TSVT) Ultime notizie

pulisher
Apr 04, 2025

Layoff Tracker: Relay Will Cut 70 Employees, Affecting Research Budget by 75% - BioSpace

Apr 04, 2025
pulisher
Mar 30, 2025

Charles Schwab Investment Management Inc. Has $1.26 Million Position in 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World

Mar 30, 2025
pulisher
Mar 13, 2025

Bristol Meyers Squibb to Acquire 2seventy bio - Contract Pharma

Mar 13, 2025
pulisher
Mar 13, 2025

2seventy bio, Inc. (NASDAQ:TSVT) Receives $7.20 Consensus PT from Analysts - Defense World

Mar 13, 2025
pulisher
Mar 11, 2025

Bristol Myers Squibb scoops up 2seventy bio for $286M - The Business Journals

Mar 11, 2025
pulisher
Mar 10, 2025

2seventy bio Enters into Definitive Agreement to be Acquired by Bristol Myers Squibb - Business Wire

Mar 10, 2025
pulisher
Mar 10, 2025

Rhumbline Advisers Has $249,000 Holdings in 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World

Mar 10, 2025
pulisher
Mar 06, 2025

2Seventy Bio at TD Cowen Conference: Strategic Growth and Challenges - Investing.com

Mar 06, 2025
pulisher
Feb 16, 2025

Analysts Set 2seventy bio, Inc. (NASDAQ:TSVT) Target Price at $7.20 - Defense World

Feb 16, 2025
pulisher
Feb 06, 2025

2seventy bio Reports Preliminary* Full-Year U.S. Abecma Sales and Select Financial Results - Business Wire

Feb 06, 2025
pulisher
Feb 05, 2025

Gossamer Study Finds Seralutinib Has Long-Lasting Effects in PAH - Managed Healthcare Executive

Feb 05, 2025
pulisher
Jan 20, 2025

Weiss Ratings Reaffirms “Sell (E+)” Rating for 2seventy bio (NASDAQ:TSVT) - Defense World

Jan 20, 2025
pulisher
Jan 04, 2025

Barclays PLC Sells 132,019 Shares of 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World

Jan 04, 2025
pulisher
Dec 18, 2024

Fmr LLC Has $701,000 Stock Holdings in 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World

Dec 18, 2024

2 Seventy Bio Inc Azioni (TSVT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Capitalizzazione:     |  Volume (24 ore):